Novozymes reported 149.72M in Cash and Equivalent for its fiscal quarter ending in December of 2023.





Cash And Equivalent Change Date
Arq USD 906K 3.77M Jun/2026
Avient USD 425.6M 2M Jun/2026
Chemours USD 671M 108M Jun/2026
Coronado Global Resources USD 173.03M 56.67M Dec/2025
Corteva USD 2.37B 401M Jun/2026
Metallus USD 108.6M 4.6M Jun/2026
Newmont Corporation USD 8.78B 3.14B Mar/2026
Novozymes 149.72M 7.92M Dec/2023
SSR Mining USD 634.09M 99.25M Mar/2026